212 related articles for article (PubMed ID: 11327542)
1. The degree of bone marrow infiltration in patients with hairy cell leukemia treated with splenectomy compatible with long-term hematological remission.
Zák P; Chrobák L; Dedic K
Neoplasma; 2001; 48(1):72-5. PubMed ID: 11327542
[TBL] [Abstract][Full Text] [Related]
2. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
3. [Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine].
Zák P; Chrobák L; Dĕdic K; Podzimek K
Vnitr Lek; 2000 Oct; 46(10):697-703. PubMed ID: 11344629
[TBL] [Abstract][Full Text] [Related]
4. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of recombinant interferon alpha-2 in 34 patients with hairy cell leukemia. Effect of splenectomy and dosage reduction results of therapy].
Frey B; Hofmann V; Cavalli F; Fehr J; Kroner T; Nesthus I; Schwarzmeier J
Schweiz Med Wochenschr; 1988 Oct; 118(41):1468-75. PubMed ID: 3238389
[TBL] [Abstract][Full Text] [Related]
7. Hairy cell leukaemia, its therapy and prognosis (historical review with own experiences).
Chrobák L; Podzimek K; Zak P; Plísková L; Voglová J
Acta Haematol Pol; 1995; 26(2 Suppl 1):56-62. PubMed ID: 7653236
[TBL] [Abstract][Full Text] [Related]
8. [Hairy cell leukemia. I.--Clinical, biological and evolutive study on twenty-eight cases (author's transl)].
Bernadou A; Pelletier G; Cadiou M; Giannoni F; James JM; Bilski-Pasquier G
Sem Hop; 1981 Sep 18-25; 57(33-36):1361-5. PubMed ID: 6270794
[TBL] [Abstract][Full Text] [Related]
9. Hairy cell leukaemia. Clinical features and effect of splenectomy.
Jansen J; Hermans J; Remme J; den Ottolander GJ; Cardozo PL
Scand J Haematol; 1978 Jul; 21(1):60-71. PubMed ID: 694419
[TBL] [Abstract][Full Text] [Related]
10. The value of bone marrow biopsy in the prognosis of hairy cell leukemia (HCL).
Podzimek K; Kerekes Z; Chrobák L; Skalská H; Voglová J; Mirová S; Dulícek P; Zák P
Neoplasma; 1994; 41(6):325-30. PubMed ID: 7870215
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of complete remission in hairy cell leukemia patients treated with alpha-IFN.
Lauria F; Foà R; Raspadori D; Pileri S; Tassinari A; Buzzi M; Zaccaria A; Zinzani PL; Tura S
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():176-8. PubMed ID: 2785426
[TBL] [Abstract][Full Text] [Related]
12. [Splenectomy in the treatment of hairy cell leukemia].
Iudin MIa; Iavorkovskiĭ LL; Liepi'nsh MA
Vestn Khir Im I I Grek; 1989 May; 142(5):39-43. PubMed ID: 2800213
[TBL] [Abstract][Full Text] [Related]
13. [Hairy cell leukemia: prognosis and treatment].
Quaresima M; Iacobelli S; Tempera S; Frattarelli N; Bizzoni L; Anaclerico B; Matturro A; Cucchi F; Tafuri A; Pulsoni A
Clin Ter; 2006; 157(2):105-9. PubMed ID: 16817498
[TBL] [Abstract][Full Text] [Related]
14. [Improvement with interferon-alpha therapy and splenectomy in hairy cell leukemia of European-American type].
Yasuyama M; Kawauchi K; Sugiyama H; Mori H; Enomoto Y; Watanabe Y; Machii T; Kitani T
Rinsho Ketsueki; 1992 Mar; 33(3):365-70. PubMed ID: 1578641
[TBL] [Abstract][Full Text] [Related]
15. Hairy cell leukemia-variant--a case report.
Gupta K; Jasmina A; Malhotra P; Varma N; Vaiphei K; Vohra H; Varma S; Garewal G
Indian J Pathol Microbiol; 2005 Jul; 48(3):387-9. PubMed ID: 16761764
[TBL] [Abstract][Full Text] [Related]
16. [Factors of an unfavorable prognosis in patients with B-cell chronic lymphoid leukemia: a retrospective analysis of 206 cases].
Nikitin EA; Lorie IuIu; Melikian AL; Samoĭlova RS; Bulycheva TI; Obukhova TN; Kaplanskaia IB; Doronin VA; Kolosova LIu; Goriacheva SR
Ter Arkh; 2003; 75(7):38-47. PubMed ID: 12934480
[TBL] [Abstract][Full Text] [Related]
17. Long-term results in hairy cell leukemia treated by splenectomy.
Chrobák L; Podzimek K; Kerekes Z; Spacek J; Voglová J
Neoplasma; 1993; 40(2):133-6. PubMed ID: 8350957
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia.
Lauria F; Lenoci M; Annino L; Raspadori D; Marotta G; Bocchia M; Forconi F; Gentili S; La Manda M; Marconcini S; Tozzi M; Baldini L; Zinzani PL; Foà R
Haematologica; 2001 Oct; 86(10):1046-50. PubMed ID: 11602410
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin profiles and blood variables in 50 patients with hairy cell leukemia. Effects of splenectomy.
Wiedermann D; Wiedermann B; Chrobák L; Indrák K; Cechácek Z
Neoplasma; 1984; 31(2):191-6. PubMed ID: 6717688
[TBL] [Abstract][Full Text] [Related]
20. [Successful treatment of hairy cell leukemia with pentostatin].
Fujita H; Koharazawa H; Nishida H; Terada S; Morishita T; Kuroyama Y; Ohata M; Ishigatsubo Y
Rinsho Ketsueki; 2001 Jul; 42(7):537-42. PubMed ID: 11524843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]